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Skeletal muscle has great regenerative capacity which is dependent on muscle stem
cells, also known as satellite cells. A loss of satellite cells and/or their function impairs
skeletal muscle regeneration and leads to a loss of skeletal muscle power; therefore, the
molecular mechanisms for maintaining satellite cells in a quiescent and undifferentiated
state are of great interest in skeletal muscle biology. Many studies have demonstrated
proteins expressed by satellite cells, including Pax7, M-cadherin, Cxcr4, syndecan3/4, and
c-met. To further characterize satellite cells, we established a method to directly isolate
satellite cells using a monoclonal antibody, SM/C-2.6. Using SM/C-2.6 and microarrays,
we measured the genes expressed in quiescent satellite cells and demonstrated that
Hesr3 may complement Hesr1 in generating quiescent satellite cells. Although Hesr1- or
Hesr3-single knockout mice show a normal skeletal muscle phenotype, including satellite
cells, Hesr1/Hesr3-double knockout mice show a gradual decrease in the number of
satellite cells and increase in regenerative defects dependent on satellite cell numbers.
We also observed that a mouse’s genetic background affects the regenerative capacity
of its skeletal muscle and have established a line of DBA/2-background mdx mice that
has a much more severe phenotype than the frequently used C57BL/10-mdx mice. The
phenotype of DBA/2-mdx mice also seems to depend on the function of satellite cells.
In this review, we summarize the methodology of direct isolation, characterization, and
molecular regulation of satellite cells based on our results. The relationship between
the regenerative capacity of satellite cells and progression of muscular disorders is
also summarized. In the last part, we discuss application of the accumulating scientific
information on satellite cells to treatment of patients with muscular disorders.
Keywords: satellite cells, skeletal muscle, maintenance, muscular diseases, quiescence, notch, microarray, cell
therapies
INTRODUCTION
One of the best-known examples of regeneration is the abil-
ity of newts to regenerate limbs and tails. This process was
believed to utilize specialized multipotent cells that have the
potential to produce all types of cells. The existence of this type
of multipotent stem cells seemed to be the reason newts, but
not humans, can regenerate limbs. However, a recent study of
the axotl has suggested a different model (Kragl et al., 2009).
Instead of multipotent stem cells, each tissue produces progen-
itor cells with restricted potential. In other words, each cell
keeps a memory of its tissue origin during regeneration. Humans
who lose a limb cannot produce new one because most types
of cells do not retain their regenerative potentials in humans.
Skeletal muscle, however, seems to be an exception. Muscle stem
cells, known as satellite cells, make it possible for humans and
newts to regenerate, because the potential for muscle regener-
ation using satellite cell-like cells is maintained across species
(Morrison et al., 2006). Because the ultimate goal of regenerative
medicine is to rebuild lost tissue, the study of muscle regen-
eration and satellite cells will help us clarify the principles of
regeneration.
How many times can skeletal muscle rebuild itself? In other
words, how many times can satellite cells proliferate to make
new myofibers in mammals? Two groups have reported a power-
ful regenerative capacity of skeletal muscle in rats and mice. Luz
et al. reported that C57BL/10 mice regenerated muscle without
loss of myofibers or gain of fibrotic areas after 50 bupivacaine
injections into the TA muscle (Luz et al., 2002). Sadeh et al.
showed active regeneration cycles in rats that had received weekly
injections of bupivacaine for 6 months. They reported a lack of
evidence for reduction or exhaustion of muscle fiber capacity
to regenerate despite ongoing degeneration–regeneration cycles
over a period approximating one fourth of the rat life expectancy
(Sadeh et al., 1985). These results clearly indicate that the satellite
cell pool is efficiently maintained during multiple degeneration–
regeneration cycles in these animals. However, actually, there are
many inherited and non-inherited muscle disorders that exhibit a
progressive loss of muscle mass and weakness. Duchenne mus-
cular dystrophy is a well-known inherited muscle disease that
results from the lack of functional dystrophin proteins. In disease
environments, satellite cells are forced to continue to proliferate
and differentiate because newly formed myofibers are repeatedly
www.frontiersin.org November 2013 | Volume 4 | Article 317 | 1
Carlos Hermano J. Pinheiro,
University of São Paulo, Brazil
Fukada et al. Studies of muscle stem cells for therapies
damaged. This regeneration–degeneration cycle is considered to
lead to exhaustion of satellite cell potentials, which is one rea-
son why dystrophic patients exhibit progressive symptoms. In
addition, the microenvironment of satellite cells in disease condi-
tions may affect long-term survival and/or maintenance of their
functions. The same genes that are responsible for inherited mus-
cle disease might directly contribute to sustaining the satellite
cell pool. Our knowledge of how to overcome and develop new
therapeutic methodologies for muscle diseases based on satellite
cell biology is still limited, but if we can manipulate satellite cell
potential, it may lead to treatment of many muscle disorders. To
accomplish this, we have to understand the molecular and cellu-
lar mechanisms of satellite cells. In this chapter, we will introduce
themethodology of direct isolation of satellite cells, which was the
first step to revealing the molecular and cellular mechanisms of
satellite cells. Next, based on recent studies, we will show molec-
ular regulation of satellite cells, and the relationship between the
capacity of satellite cells and the progression of muscular disor-
ders. In the last part, we discuss how to apply the accumulating
scientific results on satellite cells to treating patients with muscle
disorders.
SATELLITE CELLS
Satellite cells were discovered by Dr. Alexander Mauro as
mononuclear cells attached to myofibers in frog muscle (Mauro,
1961). Subsequently, satellite cells were found in mammalian
skeletal muscle. The name is derived from their location
between the basal lamina and sarcolemma (plasma membrane
of myofiber) (Figure 1A). Like other stem cells, satellite cells are
maintained in an undifferentiated and quiescent state in unin-
jured muscles (Schultz et al., 1978), and therefore, transcriptional
activity is much lower than in proliferating myoblasts. In fact, the
nucleus occupies most of the cell area, and only small portions
are observed as cytoplasm by electronic microscopy (Figure 1A).
In addition, the RNA content of quiescent satellite cells is about
one fourth of that of cultured myoblasts (Fukada et al., 2007).
Freter et al. demonstrated global suppression of RNA polymerase
II serine-2 phosphorylation, which triggers productive transcrip-
tion elongation, mRNA processing, and release of the mature
mRNA in adult stem cells including satellite cells (Freter et al.,
2010). However, recent studies show that the quiescent state is
not “passive,” but rather a highly regulated cell state that is rapidly
activated in response to injury or damage (Liu et al., 2013), there-
fore the “active” molecular regulation of stem cells is of great
interest in the field of stem cell research.
In the past 15 years, many studies have reported other myo-
genic stem/progenitor cells, for example, bone marrow cells, side
population (SP) cells, and muscle-resident interstitial cells, that
seemed to function as stem cells for muscle regeneration (Ferrari
et al., 1998; Gussoni et al., 1999; Jackson et al., 1999; Asakura
and Rudnicki, 2002; Asakura et al., 2002; Fukada et al., 2002;
LaBarge and Blau, 2002; Tamaki et al., 2002; Polesskaya et al.,
2003). However, the physiological roles of these types of cells are
limited, and, now there is no doubt that satellite cells play essen-
tial roles during skeletal muscle regeneration (Collins et al., 2005;
Lepper et al., 2011; Sambasivan et al., 2011). In addition, a sin-
gle satellite cell has potential for both myogenic differentiation
FIGURE 1 | Proteins expressed in quiescent muscle satellite cells.
(A) Location of satellite cells. PM, plasma membrane; BL, basal lamina; SC,
satellite cell. (B) Satellite cell molecules whose protein expressions are
confirmed. Red indicates “quiescence genes.”
and self-renewal; therefore, the functions and characteristics of
satellite cells satisfy the criteria of stem cells, and satellite cells
function physiologically as stem cells for skeletal muscle home-
ostasis (Sacco et al., 2008). Satellite cells also play essential roles in
skeletal muscle development. White et al. estimated that satellite
cells contribute to the increase in the number of myofiber nuclei
in mice until 3 weeks after birth (White et al., 2010).
The identification and observation of satellite cells had been
dependent on electronic microscopy. However, the discovery of
M-cadherin expression on satellite cells has allowed us to easily
identify them by conventional microscopy (Irintchev et al., 1994).
Pax7 is also widely used to identify satellite cells by microscopy.
In contrast to M-cadherin-null mice, Pax7-null mice show severe
loss of muscle mass and satellite cell pools (Seale et al., 2000).
In addition to these molecules, expression of several other pro-
teins in quiescent satellite cells has been reported (Figure 1B).
Above all, identification of cell surface molecules allows us to iso-
late living quiescent satellite cells, using a specific antibody that
recognizes the extracellular domain of the protein. In the next
section, we will introduce the history and methodologies of direct
isolation of satellite cells.
DIRECT ISOLATION OF SATELLITE CELLS
Direct isolation of stem cells is a powerful tool to investigate
their biology. Direct isolation of hematopoietic stem cells made
research on hematopoietic stem cells the cutting edge of stem cell
biology (Osawa et al., 1996). On the other hand, identification
of stem cells by culture-based methods sometimes lacks repro-
ducibility because culture conditions might affect it. Therefore,
direct isolation of stem cells is essential for the study of stem cell
biology.
When we started to study muscle satellite cells, nobody had
succeeded in direct isolation of them, although Blau’s group
reported isolation of myogenic cells using an anti-integrin a7
antibody from crude cultured mononuclear cells derived from
skeletal muscle (Blanco-Bose et al., 2001). To directly isolate
satellite cells, we tried to develop a monoclonal antibody. We
injected C2/4 cells (a subclone of C2C12) into rats, and pro-
duced hybridoma cells by a standard method. C2/4 cells were
used for FACS-based screenings because our aim was to establish
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a monoclonal antibody suited to FACS analyses. In addition,
skeletal muscle-derived mononuclear cells were also used for the
FACS-based screening process. Finally, SM/C-2.6, a new mono-
clonal antibody, was established (Fukada et al., 2004), and then we
established a method to isolate pure satellite cells using SM/C-2.6,
anti-CD31, -CD45, and -Sca-1 antibodies (Fukada et al., 2007;
Ikemoto et al., 2007). All mononuclear myogenic cells in skeletal
muscle at different stages of injury as well as uninjured muscle
were purified in the SM/C-2.6(+)CD31(−)CD45(−)Sca-1(−)
fraction (Ikemoto et al., 2007; Segawa et al., 2008). SM/C-2.6 also
contributed to the generation of myogenic cells from embryonic
stem (ES) cells and induced pluripotent stem (iPS) cells (Chang
et al., 2009; Mizuno et al., 2010). Furthermore, the antibody led
to the identification of mesenchymal progenitors, which are the
original cell sources of both the fibrosis and adipogenesis that
are the hallmarks of progressed muscular dystrophies (Uezumi
et al., 2010, 2011; Ito et al., 2013). In in vitro culture conditions,
cells easily lose in vivo characteristics, including gene expression.
In addition, a lack of purification allows contamination by other
types of cells and affects the results. Therefore, the purification
of isolated cells is essential for these analyses, and our methods
to assure the purity are widely used in many laboratories (Israeli
et al., 2007; Verma et al., 2010; Yajima et al., 2010; Tokura et al.,
2011; Urciuolo et al., 2013).
There are other methods to purify muscle satellite cells.
In 2004, Sherwood et al. demonstrated that the integrin
α7(+)integrin β1(+)Cxcr4(+)CD34(+)CD45(−)Sca-1(−)Mac-
1(−) fraction contained only myogenic cells (Sherwood et al.,
2004). In 2005, Montarras et al. showed that satellite cells
are highly enriched in the CD34(+)CD45(−)Sca-1(−) fraction
(Montarras et al., 2005). Syndecan3/4 is also used as a positive
marker of satellite cell isolation (Tanaka et al., 2009). The posi-
tive marker used depends on the laboratory, but many research
groups use the same negative markers. The positive and nega-
tive markers used for directly isolating satellite cells are listed
in Table 1. In addition to these cell surface-based methods for
isolation of satellite cells, genetic modifications also allow us
to directly isolate quiescent satellite cells. Green or yellow flu-
orescent protein expression under a Pax3 (Montarras et al.,
2005; Bosnakovski et al., 2008) or Pax7 promoter is one estab-
lished method for direct isolation of satellite cells. Unfortunately,
although information on satellite cells in humans is still limited,
SM/C-2.6 does not react with human, rat, or dog cells (unpub-
lished data). Thus, neural cell adhesion molecules (NCAM)
is used for identification of human satellite cells in tissues
(Cashman et al., 1987), and a few groups have reported direct
isolation of satellite cells using anti-NCAM (CD56) antibodies
(Dellavalle et al., 2007).
Table 1 | Markers used in the direct isolation of muscle satellite cells.
Positive markers Negative markers References
SM/C-2.6 CD31, CD45, Sca-1 Fukada et al., 2004, 2007
Integrin α7, Integrin
β1, Cxcr4
CD45, Sca-1, Mac-1 Sherwood et al., 2004
CD34 CD45, Sca-1 Montarras et al., 2005
FACS analyses do not provide information about the location
of satellite cells. In general, immunohistochemistry studies are
necessary to provide information on the location of the cells of
interest (Irintchev et al., 1994), and therefore, the expression of
positive markers on satellite cells must be examined by immuno-
histochemistry in order to isolate satellite cells. Importantly,
the positive markers for isolating satellite cells described above
were examined their expression on satellite cells by immuno-
histochemistry. Therefore, isolated cells by FACS are considered
to be equivalent to the anatomically identified satellite cells
(Beauchamp et al., 2000; Cornelison et al., 2001; Fukada et al.,
2004).
As described above, some muscle stem cells except for satel-
lite cells are identified by FACS. Muscle-SP cells are defined by
Hoechst-efflux (Gussoni et al., 1999; Jackson et al., 1999). Satellite
cells do not exist in the SP cell fraction (Fukada et al., 2004),
and therefore muscle satellite cells and SP cells are considered
to be different cell populations. Like muscle-SP cells, the other
types of muscle stem cells are located in interstitial areas in mus-
cle (Tamaki et al., 2002; Uezumi et al., 2006), and therefore SP
cells and muscle-resident interstitial cells are completely distinct
populations from satellite cells, making the study of immunohis-
tochemistry essential for using positive markers to isolate muscle
satellite cells.
However, FACS studies have many advantages in on-going
studies of stem cell biology. FACS can easily elucidate the cell
size, cellular granularity, and frequency of a stem cell population
(Fukada et al., 2011). In addition, direct isolation assures sin-
gle cell transplantation (Sacco et al., 2008), and Montarras and
Ikemoto reported that freshly isolated cells have much higher
muscle reconstitution potential than cultured cells (Montarras
et al., 2005; Ikemoto et al., 2007). Among the benefits of direct
isolation, one of the most notable is that we can perform genome-
wide gene expression analyses using isolated cells and microar-
rays. In fact, we have identified a great number of unexpected
genes in quiescent satellite cells (Fukada et al., 2007). In the next
section, we will introduce genes that are specifically or highly
expressed in satellite cells in the dormant state.
QUIESCENCE GENES
Cultured myoblasts and myogenic cell lines play important roles
in studies of myogenic differentiation, and essential processes for
myogenic differentiation have been established. Establishment of
C2 cells (Yaffe and Saxel, 1977) and the subclone C2C12 (Blau
et al., 1983a) has played extremely important roles in studies of
myogenic cell biology. Single myofiber culture is also excellent
model to investigate the differentiation and self-renewal mech-
anisms of satellite cells in vitro (Rosenblatt et al., 1995). However,
little was known about the genes expressed in quiescent satel-
lite cells until 2007 when our group first compared the genes of
quiescent satellite cells and cultured myoblasts. We found that
507 genes (665 probes) were expressed in quiescent satellite cells
at levels more than 5-fold higher than in activated satellite cells
(Fukada et al., 2007). To date, among these genes, the physio-
logical roles of Sprouty1 (Spry1), Notch3, and Cepbb, in satellite
cells have been elucidated using gene-deleted mice (Kitamoto
and Hanaoka, 2010; Shea et al., 2010; Marchildon et al., 2012).
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Spry1 is an inhibitor of receptor tyrosine kinase signaling, and
the lack of Spry1 leads to loss of the satellite cell pool during
the regeneration process. In uninjured young and adult mus-
cle, Spry1 is not essential for maintaining satellite cells, but in
aged muscle, the loss of Spry1 leads to a decrease in the num-
ber of satellite cells due to accelerated fibroblast growth factor
(FGF) signaling (Chakkalakal et al., 2012). Kitamoto et al. showed
that half of satellite cells and myoblasts express Notch3, and that
Notch3 expression is downregulated during myogenic differen-
tiation (Kitamoto and Hanaoka, 2010). Intriguingly, the loss of
Notch3 increases the number of satellite cells in uninjured mus-
cle. In addition, after repetitive muscle injuries, like repeated
CTX injections or dystrophic condition, Notch3-deficient mice
showed remarkable overgrowth of muscle mass. Notch3-deficient
myoblasts show accelerated proliferation, and Notch3-induced
myoblasts exhibit decreased BrdU-uptake. Therefore, in quies-
cent satellite cells, Notch3 might keep the cell cycle in a quiescent
state. The investigation of aged Notch3-deficient mice is expected
to explain the roles of Notch3 in satellite cells over long peri-
ods. CCAAT/enhancer binding proteins (C/EBPs) form a family
of basic leucine zipper (bZIP) transcription factors, of which
C/EBPβ is involved in many regulatory and differentiation pro-
cesses as both an activator and a repressor. The loss of Cebpb does
not affect the number of satellite cells, but C/EBPβ has the poten-
tial to induce Pax7 expression and inhibit myogenic differentia-
tion because loss of Cebpb expression in satellite cells promotes
fiber hypertrophy in vivo and cell fusion in vitro (Marchildon
et al., 2012). Like Spry1, loss of Cebpb might affect the satellite
cell pool in aged mice. In addition, our transcriptome analyses
have shown that Cebpd is also highly expressed in quiescent satel-
lite cells. Therefore, C/EBP family genes might regulate muscle
satellite cells in a physiological manner.
Bone morphogenetic proteins (BMPs) constitute a subgroup
of the transforming growth factor (TGF)-β superfamily, and
are known as myogenic differentiation regulators. Gamell et al.
reported that Bmp2 induces phosphorylation of Akt and migra-
tion of C2C12 (Gamell et al., 2008). Wang et al. indicated that
Bmp signaling positively regulates the proliferation of both fetal
myogenic progenitors and satellite cells in vivo (Wang et al., 2010).
They also indicated that BMP signaling is not active in qui-
escent satellite cells, but that proliferating satellite cells exhibit
active BMP signaling. These results indicate that quiescent satel-
lite cells do not respond to BMP signaling in their dormant state.
Intriguingly, our microarray results showed that quiescent satel-
lite cells express extremely high levels of Bmp2, 4, and 6 genes
(Fukada et al., 2007). Therefore, an unknown mechanism might
control BMP activity or translation of BMPs in quiescent satellite
cells. In BMP signaling, Smad1, Smad5, and Smad8 are specific
intracellular transducers. On the other hand, Smad2 and Smad3
transduce TGF-β signaling. Ge et al. reported that Smad3-null
mice showed a decreased number of satellite cells (Ge et al.,
2011). However, this study was performed using Smad3-null
mice, therefore, we cannot conclude that Smad3 plays direct roles
in quiescent satellite cells because myofibers of Smad3-null mice
are also affected by the lack of Smad3. However, hematopoietic
stem cells (Yamazaki et al., 2011) and some stem cells (Oshimori
and Fuchs, 2012) are controlled by TGF-β signaling. Likewise,
TGF-β might be an essential regulator for the maintenance of
satellite cells. In Table 2, we summarized the genes that affect
satellite cell numbers in uninjured adult skeletal muscle (Seale
et al., 2000; Kitamoto and Hanaoka, 2010; Angione et al., 2011;
Fukada et al., 2011; Ge et al., 2011; Hosoyama et al., 2011; Juan
et al., 2011; Bjornson et al., 2012; Chakkalakal et al., 2012; Cheung
et al., 2012; Mourikis et al., 2012).
On the other hand, 659 genes (814 probes) were upregu-
lated (>5-fold) in the activated state in our microarray results.
The most highly upregulated gene (334-fold) was Hmga2; Li at
al. demonstrated that Hmga2 plays essential roles in myoblast
proliferation andmyogenesis (Li et al., 2012). Therefore, our tran-
scriptome analyses include many functional genes that explain
satellite cell states.
As mentioned above, satellite cells occupy a unique location
and do not express the myogenic determination gene MyoD.
Therefore, we hypothesized that the genes responsible for main-
taining satellite cells are specifically expressed in quiescent satellite
cells in skeletal muscle. To isolate such genes, we also prepared
non-myogenic cells from skeletal muscle for comparison with
quiescent and activated satellite cells, and 63 genes were finally
Table 2 | Genes known to control satellite cell number in vivo.
Target molecule Experimental procedure Result* References
Pax7 Null Decreased (60 days, 0–10%) Seale et al., 2000
Hesr1 and Hesr3 Null Decreased (20 weeks, <20%) Fukada et al., 2011
Rbp-J Conditional (Pax7-CreERT2) Decreased (44 days, 20%) Bjornson et al., 2012; Mourikis et al., 2012
Rb Conditional (Pax7-CreERT2) Increased (14 days, 152%) Hosoyama et al., 2011
Notch3 Null Increased (4 months, 140%) Kitamoto and Hanaoka, 2010
Dicer Conditional (Pax7-CreERT2) Decreased (14 days, 20%) Cheung et al., 2012
Smad3 Null Decreased (50%) Ge et al., 2011
Sprouty Conditional (Pax7-CreERT2) Decreased (22 months, 50%) Chakkalakal et al., 2012
PPARd Conditional (Myf5-Cre) Decreased (2–3 months, 60%) Angione et al., 2011
Ezh2 Conditional (Pax7-Cre) Decreased (60 days, 60%) Juan et al., 2011
*Percentage shows the frequency of satellite cell number compared to control mice. In the case of null mice, the period shows age of mice analyzed. In the case
of Pax7-CreERT2 mice, the period after last injection of tamoxifen is indicated.
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identified as “quiescence genes,” which are highly expressed in
quiescent satellite cells but not in cultured myoblasts and non-
myogenic cells in skeletal muscle (Fukada et al., 2007). Almost
none of the genes had been previously reported in skeletal muscle
biology.
Other groups also performed similar comparisons to charac-
terize quiescent satellite cells. Pallafacchina et al. compared the
gene expression profiles of quiescent satellite cells with samples
of neonatal satellite cells and mdx mouse-derived Pax3+ cells
(Pallafacchina et al., 2010). Our “quiescence genes” are expressed
at higher rates in quiescent satellite cells than in neonatal satel-
lite cells, but the ratio is not very significant. This discrepancy
is dependent on the type of cells used for comparison because
Pallafacchina et al. also showed significant differences between
quiescent satellite cells and cultured myoblasts. Pallafacchina
et al. isolated quiescent satellite cell-specific genes (e.g., Apoe,
Ms4a4d, Fgl2, Timp4, Adh1, Ahr, Osmr), but these genes are also
expressed in non-myogenic cells in skeletal muscle. Another dis-
crepancy is the expression of Notch-related genes in quiescent
satellite cells. We identified Notch signaling-related genes (Notch3
and HeyL/Hesr3) as the most highly expressed genes in quies-
cent satellite cells, although Pallafacchina’s results did not show
the importance of Notch signaling in quiescent satellite cells.
However, recent studies have clearly demonstrated the essential
roles of Notch signaling for maintaining quiescent satellite cells
in vivo as well as developmental stages (see below). On the other
hand, quiescent satellite cells share common features in our and
Pallafacchina’s results, for example, some cell adhesion molecules
and transcriptional factors. Although our reports had not men-
tioned it, Pallafacchina et al. intriguingly found up-regulation of
anti-oxidative genes in quiescent satellite cells. In fact, our original
data also included ant-oxidative genes in quiescent-stage specific
manner. These results imply the importance of oxidative stress
in quiescent satellite cells. Farina et al. analyzed gene expressions
of quiescent satellite cells, activated satellite cells (ASC, 12 h after
injury), and proliferating myoblasts (Prof. SC, 48 h after injury)
(Farina et al., 2012). Their study focused mainly on the RNA-
binding proteins that are highly expressed in quiescent satellite
cells compared to ASC or Prof. SC. However, Zfp36 was the sole
common RNA-binding protein among the three microarray stud-
ies. Transcriptional and translational regulation of RNA may be
essential for maintaining satellite cells in a dormant state, so qui-
escent satellite cell-specific expressions of RNA-binding proteins
were limited in the three studies. The three microarray stud-
ies are summarized in Table 3. In the next sections, we would
like to introduce our three “quiescence genes”: Hesr3, calcitonin
receptor, and Odz4, with some speculation about their roles.
NOTCH EFFECTOR GENES AND SATELLITE CELLS
Notch signaling is essential for development of diverse tissues
(Lai, 2004). When Notch is activated, its intracellular domain is
cleaved by γ-secretase and it translocates to the nucleus, where
it activates the transcription of target genes through interaction
with Rbpj. Rbpj-mediated Notch signaling is known as the canon-
ical pathway, and the families of Hes (hairy and enhancer of
split) and Hesr (hes-related, also known as Hey/Herp/Hrt/Chf)
are known as primary targets of Notch signaling (Iso et al.,
2003; Fischer and Gessler, 2007). Among Hes and Hesr fam-
ily genes, quiescent satellite cells specifically and highly express
Hesr3 in skeletal muscle. Quiescent satellite cells also express
Hesr1. However, Hesr1 is not included in the ‘quiescence genes’
because endothelial cells in skeletal muscle, as well as other tis-
sues, express Hesr1. In addition, when primary myoblasts or
C2C12 are stimulated with Delta-like 1 or 4, respectively, Hesr1
and Hesr3 are induced in both types of cells (Buas et al., 2009;
Fukada et al., 2011). Therefore, Hesr1 and Hesr3 seem to be the
major downstream targets of Notch signaling in adult satellite
cells (Yamaguchi and Fukada, 2013).
The roles of Notch signaling are powerful and complicated
because it has opposite effects on some lineage cells. In myogenic
cells, Notch signaling has two roles: one is inducing myogenic
commitment and the other is inhibitingmyogenesis. Dezawa et al.
produced myogenic cells from bone marrow stromal cells via the
transient activation of Notch signaling in the processes (Dezawa
et al., 2005). Rios et al. reported that neural crest-derived delta-
like 1 transiently activates Notch signaling in cells located in the
medial border of the dermomyotome and that this event is essen-
tial for the induction of bothMyf5 andMyoD in them (Rios et al.,
2011). They also showed that sustained Notch signaling inhibits
myogenic differentiation even in the medial border of the der-
momyotome. These results demonstrated that transient Notch
signaling works as an inducer of myogenesis. On the other hand,
the myogenic inhibitory effect of Notch signaling is extremely
well known (Kuroda et al., 1999). Induction of Notch signaling
suppresses the expression of MyoD, and myogenic differentiation
is strongly inhibited. Hesr1 and Hesr3 also seem to play roles
in anti-myogenic differentiation because unusual expressions of
MyoD and myogenin were observed in satellite cells derived
from Hesr1/Hesr3 double-knockout mice (Fukada et al., 2011).
Although Hesr1 or Hesr3 single-knockout mice did not show
any defect in skeletal muscle including satellite cells and regen-
erative potential, Hesr1/Hesr3 double-knockout mice showed a
remarkable defect in satellite cells. Therefore, in adult satellite
cells, Notch signaling seems to be activated constitutively to work
as a myogenic inhibitor.
Vasyutina et al. demonstrated the essential roles of canon-
ical Notch signaling to generate the satellite cell pool during
embryonic development using conditional depletion of Rbp-
J (Vasyutina et al., 2007). However, in Hesr1/Hesr3 double-
knockout mice, most of the satellite cell pool existed in mice
by the 7th day after birth. These results suggest that the
downstream target of Notch is changed during skeletal mus-
cle development. Using Rbpj-floxed and Pax7-CreERT2 mice,
two independent groups reported the essential role of Notch
signaling for maintaining satellite cells in an undifferentiated
state in mouse adult skeletal muscle (Bjornson et al., 2012;
Mourikis et al., 2012). When Rbpj was depleted in satellite
cells by injection of tamoxifen, quiescent satellite cells started
to express myogenic proteins (MyoD and myogenin) and then
fused with myofibers. Although further study of conditional
Hesr1/Hesr3 depletion remains to be done, these results suggest
that the Notch/Rbp-J/Hesr1/Hesr3 pathway is essential to main-
tain adult satellite cells in a quiescent and undifferentiated state
(Yamaguchi and Fukada, 2013). In Table 2, we summarized the
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Table 3 | Molecular signatures of quiescent satellite cells identified by three independent studies.
Fukada et al. (2007) Pallafacchina et al. (2010) Farina et al. (2012)
Comparison Cultured myoblasts,
NON-myogenic cells
1-week neonatal SC, mdx SC In vivo activated SC12,
48 h, Syndecan-4-null
Method
Isolation SM/C-2.6+CD45- Pax3-GFP Syndecan-3
Muscle Limb muscles Diaphragm, pectoralis, and
abdominal muscles
Limb muscles
Microarray MOE430A (Affymetrix) MOE430v2 (Affymetrix) MOE430v2 (Affymetrix)
Quiescence genes*
Calcr QSC>ASC (×74) QSC>ASC (×1.8) ND
Nap1l5 QSC>ASC (×62) QSC>ASC (9.9) ND
Odz4 QSC>ASC (×24) QSC>ASC (×1.96) ND
Pde4b QSC>ASC (×23) QSC>ASC (×5.77) QSC>ASC (×11.21)
Pof1b QSC>ASC (×23) QSC>ASC (×2.79) ND
RhoH QSC>ASC (×17) QSC>ASC (×3.9) ND
Cebpb QSC>ASC (×16) QSC>ASC (×3.19) ND
Maff QSC>ASC (×14) QSC>ASC (×3.19) ND
Quiescence genes**
Apoe QSC>ASC (×293) QSC>ASC (×23) ND
Dpt QSC>ASC (×199) QSC>ASC (×2.2) ND
Ms4a4d QSC>ASC (×144) QSC>ASC (×78) ND
Adh1 QSC>ASC (×55) QSC>ASC (×28) ND
Osmr QSC>ASC (×37) QSC>ASC (×26) ND
Fgl2 QSC>ASC (×23) QSC>ASC (×42) ND
Timp4 QSC>ASC (×12) QSC>ASC (×49) ND
Ahr QSC>ASC (×8) QSC>ASC (×48) ND
Cell adhesion Chodl, Eva1, CD34, Aoc3, Tek,
Icam1, Pcdhb9. Efs, Esam1,
Cdh5, Cldn5, Nope, Itgb5, Emcn,
Cdh13, Sdc4, Dcn, Pcdh9n
Itgb1, CD24, Sdc4, Cldn1, Eva1,
CD38, Esam1, Smoc2, Icam2,
Cldn5, Dcn, Fgl2
Sdc4, Pak1, Pcdh18,
Col3a1
Notch QSC high (Notch3, HeyL) QSC low QSC high (HeyL)
Anti-oxidative stress Cyp4b1, Gstt1, Gstt3, Sod3,
Ugt1a2, Ahr, Cp, Gpx3, Cyp2d22,
Cyp39a1, Cyp27a1
Sult1a1, Cyp4b1, Abcd1a, Ugt1,
Fmo2, Ahr, Gstm1, Cyp26b1,
Srxn1, Txnrd1, Cp, Gpx3
ND
Transcriptional
factors
Sox17, Meox2, Sox7, Sox18, Klf4,
9, 15
Sox17, Meox2, Sox7, Sox18, Klf7,
Dach1, Prdm16
ND
RNA-binding protein Rnase4, Zfp36, Zfp36l1, Rnpc2,
Csdc2
Rnase4, Ddx5, Sfrs3, Son, Zfp36,
Ddx58, Rbpms
Cherp, Ddx5, Hnrnpc,
Sfrs3, Snrpb, Snrpe, Son,
Srrm1, U2af1l4, Zranb2,
Eif4h, Hnrpdl, Poldip3,
Rpl22, Rps23, Rps9,
Khdrbs1, Rnaset2a,
Zfp36, Zfp36l1, Ddx58,
Mex3b, Qars, Rad21,
Rbm26, Rbpms
ND, Not described. *“Quiescence genes” of our analyses. These genes are highly expressed in quiescent satellite cells more than in non-myogenic cells in skeletal
muscle. **These genes are highly expressed in quiescent satellite cells, but not listed in our “quiescence genes” because non-myogenic cells also expressed these
genes.
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phenotypes of Rbp-J-null and Hesr1/Hesr3-dKO mice in adult
skeletal muscle.
Melanocyte, intestinal, and neural stem cells also use canoni-
cal Notch signaling for their maintenance (Moriyama et al., 2006;
Imayoshi et al., 2010; Pellegrinet et al., 2011). In these three stem
cells, Hes1 is the major downstream target of Notch signaling.
Although the downstream target of Notch signaling is not con-
served, canonical Notch signaling seems to be a commonmolecu-
lar mechanism tomaintain stem cells in some adult tissues. Notch
signaling is essential for the differentiation of hematopoietic cells,
but hematopoietic stem cells do not require Notch signaling for
maintenance (Maillard et al., 2008).
As described, Notch signaling seems to be one of the essential
signaling pathways for maintaining satellite cells. The activa-
tion of Notch signaling is induced by its specific ligands, Dll1,
Dll4, and Jagged. Basically, direct cell–cell contact is necessary
to induce Notch signaling. Until now, the ligand and its ori-
gin for maintaining the satellite cell pool have been unclear.
Satellite cells are directly attached to myofibers, and therefore,
myofibers may express the ligand. Another possibility is that
released ligand activates Notch signaling in satellite cells. Sun
et al. indicated that Dll1 can be shed and act on myoblasts in
an autocrine manner (Sun et al., 2008). The other possibility is
ligand-independent activation of Notch receptors. Sima protein,
an ortholog of mammalian hypoxia-inducible factor-α (HIF-α),
colocalizes with Notch in endocytic vesicles and enables cleav-
age of the intracellular domain of Notch in Drosophila blood
cells (Mukherjee et al., 2011). Gustafsson et al. also demonstrated
that HIF-α interacts with the Notch intracellular domain and pro-
motes the expression of the Notch target genes (Gustafsson et al.,
2005). The role of HIF-α in muscle satellite cells is still unknown,
but these pathways may be used to activate Notch signaling in
adult satellite cells.
NOTCH SIGNALING AND OTHER SIGNALING PATHWAYS
Cross-talk signals between Notch and other pathways in some
types of cells are reported. For example, Hes proteins promote
Stat3 phosphorylation and activation through association with
Jak2 and Stat3 in neuroepithelial cells (Kamakura et al., 2004).
BMP and Notch signaling also have synergistic effects. Dahlqvist
demonstrated that BMP-induced inhibition ofmyogenic differen-
tiation requires Notch signaling (Dahlqvist et al., 2003). However,
phosphorylation of neither Stat3 nor Smad1/5/8 (downstream
targets of BMP signaling) was observed in quiescent satellite cells
(Kami and Senba, 2002; Wang et al., 2010). Therefore, these sig-
naling pathways do not seem to work coordinately with Notch
signaling to sustain the satellite cell pool, although they might
work together to activate or start proliferation of satellite cells
because phosphorylated Stat3 nor Smad1/5/8 are observed in
activated or proliferating satellite cells.
In endothelial cells, Notch signaling inhibits the phosphory-
lation of Rb (a driver of cell cycle progression), which leads to
a decrease in BrdU uptake (Noseda et al., 2004). Rb is a well-
known tumor suppressor gene, and phosphorylation of Rb allows
the cell cycle to progress. Hosoyama et al. demonstrated that Rb-
conditional depletion increased the number of satellite cells in
uninjured muscle (Hosoyama et al., 2011). Therefore, even in
quiescent satellite cells, Notch signaling might inhibit the phos-
phorylation of Rb to suppress cell cycle progression. However,
the expression of proliferative markers (Ki67 and phosphorylated
histone-H3) was not observed in Rb-cKO satellite cells, as it was
in Rbp-J cKO satellite cells. Therefore, these results suggest that
Rb-independent quiescence mechanisms are regulated by Notch
signaling, which plays roles in maintaining the satellite cell pool
in dormant state.
Ge et al. reported that Smad3-null mice had a decreased num-
ber of satellite cells (Ge et al., 2011). Using the myogenic cell line
C2C12, Blokzijl et al. indicated that TGF-β stimulation induces
Hes1 expression in a Notch signaling activation-dependent man-
ner (Blokzijl et al., 2003). Furthermore, Smad3 interacts directly
with NICD and binds to the promoter regions of Notch target
genes via Rbp-J. Therefore, in quiescent satellite cells, TGF-β and
Notch might work cooperatively to sustain the dormant state.
CALCITONIN RECEPTOR AND Odz4 AND SATELLITE CELLS
Calcitonin is a molecule that is well known to regulate home-
ostasis of the calcium level in the blood (Becker et al., 2002).
Calcitonin is released from the thyroid and works in bone and
kidney. The action of calcitonin is mediated by its specific recep-
tor, the calcitonin receptor. The calcitonin receptor is a G-protein-
coupled seven transmembrane protein. Expression of calcitonin
receptor is well known in osteoclasts, which play essential roles
in bone absorption, and results in the release of calcium into the
blood. The balance between osteoclasts and osteoblasts is tightly
regulated to maintain bone homeostasis. When the balance is
tipped toward osteoclasts, the osteoclastic process is accelerated,
and osteoporosis occurs. Calcitonin receptor signaling inhibits
the function of osteoclasts via protein kinase A (Suzuki et al.,
1996); therefore, synthetic calcitonin is used for treatment of
osteoporosis. We found specific expression of calcitonin recep-
tors in quiescent satellite cells, but not in activated satellite cells.
The expression of calcitonin receptors seems to be specific in
quiescent satellite cells because the re-expression of calcitonin
receptors during the regenerative process is related to the end
of muscle regeneration (Fukada et al., 2007; Yamaguchi et al.,
2012). Therefore, these specific expression patterns imply that cal-
citonin receptors play several roles in maintaining satellite cells in
a quiescent state. In fact, we observed that activation of calcitonin
receptors by its ligand delays activation of satellite cells in vitro
(Fukada et al., 2007). Calcitonin receptor-null mice die in utero,
and thus the roles of calcitonin receptors in myogenic lineage cells
remain unknown. To reveal the physiological importance of calci-
tonin receptors in satellite cells, the study of satellite cell-specific
deletion of calcitonin receptors is essential, and is one of our most
important ongoing investigations.
Although the physiological importance of calcitonin recep-
tors in satellite cells is unclear, Cheung et al. demonstrated that
mir-489, which is located in intron 4 of the calcitonin recep-
tor gene, is essential for satellite cell quiescence (Cheung et al.,
2012). Mir-489 is also specifically expressed in quiescent satellite
cells like calcitonin receptor mRNA. Because coding and non-
coding genes are often transcribed simultaneously, transcription
of calcitonin receptor genes is tightly regulated in satellite cells,
and investigations of calcitonin receptor gene regulation might
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elucidate the activation or self-renewal mechanism of satellite
cells.
Odz is the vertebrate homolog of the Drosophila odd Oz. Odz
family proteins belonging to the type II transmembrane protein
family (Levine et al., 1994). Onemember of the Odz family, Odz4,
is highly expressed in the central nervous system, developing eyes,
and somites (Zhou et al., 2003). In addition, we reported the
expression of Odz4 protein in satellite cells (Yamaguchi et al.,
2012). The function of Odz4 is little known, but recent reports
demonstrated the importance of Odz in oligodendrocyte differ-
entiation and process formation (Suzuki et al., 2012). They also
indicated that focal adhesion kinase, a key regulator of cell adhe-
sion, is activated downstream of Odz4. Therefore, in satellite cells,
Odz4 might control cell adhesion and/or differentiation. Odz4
and calcitonin receptor are expressed in quiescent satellite cells
but not in proliferating myoblasts. Intriguingly, the timings of
Odz4 and calcitonin receptor re-expression during skeletal mus-
cle regeneration are different (Yamaguchi et al., 2012). Currently,
we do not know the characteristics of Pax7(+)Odz4(+)calcitonin
receptor(−) cells, but we have speculated that this type of cell con-
tributes to the maturation of myofibers because the appearance
of Pax7(+)Odz4(+)calcitonin receptor(−) cells is observed dur-
ing maturation of immature myofibers (Figure 2). Like calcitonin
receptor genes, the Odz4 intron contains a quiescent satellite cell-
specific microRNA, mir-708 (Cheung et al., 2012). The function
of mir-708 is also unknown, but the gene expression mecha-
nism of Odz4 might be important for efficient skeletal muscle
regeneration.
BONE AND SKELETAL MUSCLE MAY USE COMMONMOLECULES FOR
MAINTENANCE
Skeletal muscle works as a locomotorium in cooperation with
bone. Some diseases or environmental conditions affect both
skeletal muscle and bone. For instance, inactivity, as seen in a
gravity-free state or bed rest, leads to the loss of muscle weight
and bone density. Aging and muscular dystrophy also affect
both skeletal muscle and bone states. Duchenne muscular dys-
trophy patients have low bone mineral density and increased risk
FIGURE 2 | Expressions of calcitonin receptor (CTR) and Odz4 proteins
during skeletal muscle regeneration. Pax7+MyoD-CTR-Odz4+ cells are
frequently observed during myofiber maturation.
of fractures (Bachrach, 2005). Although it has been considered
that the bone impairment of DMD patients results from mus-
cle weakness, the bone-skeletal muscle system might have direct
regulatory networks via cytokines or exosomes. Otherwise, the
bone and skeletal muscle systems use a similar gene network to
maintain their homeostasis.
Hesr1/Hesr3 are essential for generation of quiescent satel-
lite cells and to maintain their numbers in adult skeletal mus-
cle. Hesr1/Hesr3 double knock-out mice have other phenotypes
besides that of satellite cells. Fischer et al. reported that dele-
tion of both Hesr1 and Hesr3 causes severe heart malformations,
including membranous ventricular septal defects and dysplastic
atrioventricular and pulmonary valves (Fischer et al., 2007). In
addition, Tu et al. demonstrated the essential roles of Hesr1/Hesr3
in osteoblasts (Tu et al., 2012). As is well known, expression
of calcitonin receptors in osteoclasts is essential to sustain the
homeostasis of bone. Although the physiological importance of
calcitonin receptors remains unknown, Hesr1/Hesr3 and calci-
tonin receptor might be common regulators for both bone and
skeletal muscle systems.
QUIESCENCE GENES AND CANCER PROGRESSION
The quiescent state includes two types of cell cycles, reversible and
irreversible. Myofibers are mitotically quiescent, and it is an irre-
versible state. The induction of msx1 in myotubes (which are also
irreversibly quiescent) leads to the generation of mononuclear
cells that proliferate (Odelberg et al., 2000). This phenomenon is
biologically interesting, but myotubes and myofibers do not gen-
erate mononuclear cells in a physiological manner. On the other
hand, stem cells, including satellite cells, are in a reversible qui-
escent state. The molecular mechanisms of reversible quiescence
are an interest of many investigators. Reversible quiescence is con-
served from yeast to human cells to maintain particular cells,
including stem cells, in the body. Uncontrolled reversible quies-
cencemechanisms can lead to cancer. Intriguingly, Spry1, Notch3,
Cebpb, calcitonin receptor, and Odz4 are reported to relate to
cancer cells (Wang et al., 1999; Kwabi-Addo et al., 2004; Thomas
and Shah, 2005; Park et al., 2006). Cell cycle inhibitors (cyclin-
dependent kinase inhibitors) are highly expressed in stem cells,
and their breakdown leads to abnormal cell cycle regulation and
results in cancer development. Sang et al. indicated that Hes1 is
a key transcriptional factor for reversible cellular quiescence in
human fibroblasts (Sang et al., 2008). The authors also showed
that Hes1 allows human rhabdomyosarcoma cells to evade dif-
ferentiation and irreversible cycle arrest. As described above,
melanocyte stem cells, intestinal stem cells, and neural stem cells
require Hes1 downstream of Notch signaling to maintain their
pool. Therefore, elucidation of the quiescence mechanisms of
stem cells, including satellite cells, will shed light on the princi-
ple of the quiescent state, and may lead to the discovery of new
therapeutic targets for cancers.
RELATIONSHIP BETWEEN SATELLITE CELLS AND MUSCLE
DISORDERS
Muscular dystrophies are the best known muscle disorders, and
investigations of them have been central to exploring skeletal
muscle biology. The loss of satellite cell numbers and function
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is considered to be one reason why many muscular dystro-
phies exhibit progressive symptoms. Besides muscular dystro-
phies, there are many muscle disorders that exhibit a relationship
with impairments of satellite cells. In addition, some reports have
shown the direct contribution of satellite cells to the disease con-
dition. For instance, the appearance of fibrosis and adipocytes
had been considered to be due to satellite cell transdifferentia-
tion into fibroblasts and adipocytes (Asakura et al., 2001; Li et al.,
2004; Alexakis et al., 2007). However, recent studies have demon-
strated that satellite cells cannot differentiate into adipocytes and
fibroblasts (Joe et al., 2010; Uezumi et al., 2010, 2011; Starkey
et al., 2011). Consistent with these observations, Crist et al. clar-
ified that satellite cells are committed progenitor cells especially
linked to myogenic cells (Crist et al., 2012). In this section, we will
focus on the relationship between satellite cell myogenic potential
and disease progression in three muscle disorders and discuss the
contribution of satellite cell function to these disorders.
DIFFERENCE BETWEEN HUMANMUSCULAR DYSTROPHY AND MOUSE
MODEL
Duchenne muscular dystrophy (DMD) is a well-known inherited
muscular disorder, and the causative gene,Dystrophin, is coded in
the X-chromosome (Koenig et al., 1988). Patients exhibit progres-
sive symptoms, and histologically, accumulation of fibrosis and
adipocytes and loss of myofibers are observed. The Dystrophin
gene encodes a 427-kDa cytoskeletal protein that forms the dys-
trophin/glycoprotein complex at the sarcolemma with α- and
β-dystroglycans, α-, β-, γ-, ε-, and δ-sarcoglycans, and other
molecules, and links the cytoskeleton proteins of myofibers to
the extracellular matrix in skeletal muscle (Ervasti and Campbell,
1993). It is supposed that the loss of dystrophin leads to the
degeneration of myofibers due to a disturbance in assembly of the
dystrophin/glycoprotein complex.
The mdx mouse (the correct nomenclature is C57BL/10-
DMDmdx) is the most widely used model animal of DMD
(Bulfield et al., 1984). Although mdx mice have a mutation in the
dystrophin gene and show degeneration of myofibers, the symp-
toms of mdx mice are remarkably milder than those of DMD
patients. In contrast with DMD patients, accumulation of fat and
fibrosis inmdx mice are barely observed except in the diaphragm,
and neither myofibers nor muscle weight are lost throughout
much of their life span. One reason for the difference between
DMD and mdx is explained by the excellent regeneration capac-
ity of mdx compared with DMD. However, mdx mice carrying
another strain background (DBA/2) show similar phenotypes
to humans; loss of muscle weight, increased fibrosis, accumula-
tion of adipocytes, and decreased muscle force (Fukada et al.,
2010). Intriguingly, satellite cell functions of DBA/2 also differ
from those of C57BL/6 mice. Therefore, one of reason for the
severe phenotype of DBA/2-mdx seems to be inferior function of
satellite cells compared to C57BL/10-mdx.
The life spans of mice and humans are completely different. In
humans, long-term proliferation of satellite cells might be neces-
sary. However, the human telomere is much shorter than that of
the mouse. Based on this, Sacco et al. hypothesized that the longer
telomere allows satellite cells to proliferate repeatedly in mice. To
elucidate this hypothesis, they generated mdx mice lacking the
RNA component of telomerase (mdx/mTR) and demonstrated
that mdx/mTR mice exhibit severe muscular dystrophy and a
decrease in the loss of satellite cell proliferation (Sacco et al.,
2010). The phenotypes of DBA/2-mdx are unlikely dependent on
the telomere erosion because DBA/2 mice have longer telomeres
than C57BL/6 (Manning et al., 2002). These results indicate that
the differences between human and mouse models depend on
several functions of satellite cells: one is telomere length, but the
other factors are unknown.
Other dystrophic mouse models, gamma-sarcoglycan-null
mice, also depend on the mouse genetic background, and DBA/2-
backgroundmice exhibit the most severe phenotype of the strains
examined (Heydemann et al., 2005). Intriguingly, the aged phe-
notype of DBA/2 is much more severe than that of C57BL/6
(Lionikas et al., 2006). In addition, the low reconstitution poten-
tial of the DBA/2-strain is not restricted to skeletal muscle.
DBA/2-derived hematopoietic stem cells (HSCs) show low recon-
stitution, and Liang et al. revealed the gene, latexin, responsible
for this phenotype (Liang et al., 2007). These results suggest that
similar analyses will also lead to the discovery of genes responsible
for skeletal muscle satellite cells, which may lead to the discovery
of a new therapeutic methodology for muscular disorders.
MUSCULAR DYSTROPHY AND SATELLITE CELLS
Conceptually, exhaustion of the satellite cell pool leads to the pro-
gression of muscular dystrophy. In fact, the loss of proliferative
potential was observed in myoblasts derived from DMD patients
(Blau et al., 1983b). One of our surprising findings was that qui-
escent satellite cells showed high expressions of dystrophin and
dystroglycan genes compared to myoblasts (Fukada et al., 2007).
Both dystrophin and dystroglycan have been considered essential
proteins for stability of the myofiber membrane (sarcolemma),
and it is well known that the lack of these genes leads to mus-
cular dystrophies. The roles of these genes in satellite cells are still
unknown, but these genes might be essential for cell adhesion and
stability of satellite cells as well as myofibers.
Recently, Kanagawa et al. showed a functional defect of myo-
genic cells in the mouse model of Fukuyama-type congenital
muscular dystrophy, which is caused by an ancient retrotrans-
posal insertion in the Fukutin gene (Kobayashi et al., 1998;
Kanagawa et al., 2013). Interestingly, fukutin-deficient myoblasts
showed a significantly low potential for myotube formation,
even myoblasts that originated from mice that had not started
to exhibit a dystrophic phenotype. These results indicate that
fukutin is necessary for myotube formation; therefore, efficient
regeneration is likely to be impaired in Fukuyama-type mus-
cular dystrophy. In addition, lamin A/C and emerin, which are
expressed in quiescent satellite cells, are known as causal genes
for autosomal-Emery-Dreifuss muscular dystrophy (A-EDMD)
(Bonne et al., 1999) and X-EDMD (Bione et al., 1994), respec-
tively. Therefore, some causative genes for muscular dystrophy
may affect satellite cells and/or their daughter cells directly, which
might determine the severity of symptoms (Gnocchi et al., 2008).
SARCOPENIA AND SATELLITE CELLS
Current progress and improvement of medical treatment pro-
long lives, but aging-related physical morbidity is becoming a
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social problem. Normal skeletal muscle also faces these prob-
lems. Most of us exhibit drastic deterioration of performance
with age. One cause is sarcopenia, which is linked to the loss of
muscle mass and function. Sarcopenia is inevitable, and likely
to contribute to the decline of muscle strength and ability to
maintain daily activities. Some researchers define sarcopenia
as “an appendicular muscle mass/height2 less than two stan-
dard deviations below the mean for that of a young healthy
adult” (Iannuzzi-Sucich et al., 2002). According to this defini-
tion, the percentage of elderly suffering from sarcopenia has
reached 10–25% or more (Baumgartner et al., 1999). In light
of this severe phenomenon and the tendency of the global geri-
atric population to increase in number, sarcopenia will become
a social problem. Besides sarcopenia, there are other muscle
disorders accompanying the loss of muscle mass, known as atro-
phies. However, sarcopenia can be distinguished from other types
of muscle atrophy by a decrease in the number of myofibers.
Myofiber formation is based on the fusion of a large number of
myoblasts (Moss and Leblond, 1970; Hawke and Garry, 2001)
and requires the participation of satellite cells in the regenera-
tive process of myofibers; a relationship between satellite cells
and sarcopenia is possible, although it still remains controversial.
Trendelenburg et al. demonstrated that TAK-1/p38/nNF-κB sig-
naling pathway inhibits myoblast differentiation by increasing the
level of activin A (Trendelenburg et al., 2012). Upregulation of
TNF-1α and IL-1β is reported in sarcopenia, and they drive TAK-
1/p38/nNF-κB. The NF-κB pathway is well known as an inducer
of muscle atrophy (Cai et al., 2004). Therefore, the NF-κB path-
way might be activated in both satellite cells and myofibers, which
leads to suppression of myogenic differentiation and atrophy in
myofibers.
In sarcopenia, direct contributions by the satellite cell pool
are proposed because many studies have demonstrated the loss
of satellite cell pools throughout the aging period. In contrast,
some reports indicate that the number of satellite cells in mus-
cle of elderly rats and mice is unchanged. Although it has not
been fully elucidated, the discrepancy is likely to be connected to
a difference in the muscle tissues analyzed (e.g., levator, soleus,
vastus lateralis, and tibialis anterior, etc.) (Gibson and Schultz,
1983; Nnodim, 2000; Brack et al., 2005; Schafer et al., 2005).
Based on the fact that sarcopenia mainly presents a decline in
type 2 muscle fibers, some researchers have confirmed the obser-
vation of a 45% reduction in satellite cell numbers in type 2
muscle fibers in old (76± 1 years) vs. young (20± 1 years) pop-
ulations (Verdijk et al., 2007). In addition, several available tests
demonstrate that activated satellite cells can partially counter sar-
copenia (Cutlip et al., 2009; Snijders et al., 2009; Aagaard et al.,
2010). These backgrounds contribute to the maximal connec-
tion between satellite cells and sarcopenia. Intriguingly, DBA/2
strain mice exhibit a more remarkable loss of muscle mass than
C57BL/6 mice, and the satellite cell pool of DBA/2 is reduced
earlier in their life span than that of C57BL/6 (our unpub-
lished data). As described in the previous section, DBA/2 satellite
cells are inferior to those of C57BL/6 mice, and therefore, the
investigation of DBA/2-satellite cells might lead to discovery of
the central pathway for the maintenance of satellite cell pool
throughout life.
CANCER CACHEXIA AND SATELLITE CELLS
Some cancers induce the loss of body weight. A decrease beyond
5% of body weight in 12 months or less can be defined as can-
cer cachexia. Because skeletal muscle mass occupies about 40%
of body weight, cancer cachexia is generally associated with the
loss of muscle weight. Although the molecular mechanism evok-
ing muscle atrophy in cancer cachexia patients remains largely
unknown, some studies have begun to reveal the molecular
mechanisms of cancer cachexia. Acharyya et al. indicated that
dysfunction of dystrophin in a cancer cachexia mouse model
leads to weakness of the myofiber membrane (Acharyya et al.,
2005). The membrane structure of myofibers is considered an
important element for maintaining the satellite cell pool, and
therefore, there is a possibility that a change in the myofiber
membrane affects satellite cells. In fact, Penna et al. found an
increased number of satellite cells in cancer cachexia model mice
(Penna et al., 2010). Further, up-regulation of TNF-α and IL-6
in cachexia patients and animal models is well known. Although
the relationship between these cytokines and muscle wasting is
unclear, these cytokines inhibit muscle differentiation (Coletti
et al., 2002, 2005; Guttridge, 2004). Zhou indicated that activa-
tion of ActRIIB (receptor for activin and myostatin) contributes
to the loss of mass in cancer cachexia model mice and that an
ActRIIB antagonist may be a therapeutic approach to the treat-
ment of cancer cachexia (Zhou et al., 2010). As described for
sarcopenia, the ActRII signaling pathway inhibitsmyogenic differ-
entiation. Based on this information, it is possible to hypothesize
that cancer cachexia involves satellite cell dysfunctions. In this
case, satellite cells may be directly targeted for the treatment of
cancer cachexia, and a molecular mechanism for regulation of
satellite cells may solve this problem in the near future. In addi-
tion, recently it was reported that muscle stromal cells (PDGFRa+
cells, which are considered to be mesenchymal progenitors) are
essential to sustain muscle mass (Roberts et al., 2013). Depletion
of muscle stromal cells leads to the loss of muscle mass, and can-
cer cachexia induced a decrease in the number of muscle stromal
cells. Therefore, muscle mesenchymal progenitors might be also a
direct target of cancer cachexia as well as muscle satellite cells and
myofibers.
FUTURE STRATEGIES FOR STEM CELL RESEARCH TO TREAT
MUSCLE DISORDERS
Satellite cells undoubtedly have the best potential to produce new
myofibers in vivo. However, there are obstacles to overcome. One
problem is the lowmigration potential of satellite cells. Mostmus-
cular dystrophy patients have dystrophic symptoms in systemic
skeletal muscles; therefore, satellite cells have to be transplanted
via blood vessels. Unfortunately, satellite cells cannot cross blood
vessels, so the use of satellite cells is considered limited to the
relatively localized muscle diseases such as oculopharyngeal mus-
cular dystrophy (OPMD). Recently, Cappellari et al. reported that
Dll4 and PDGFβ signals convert myogenic cells to pericyte-like
cells without erasing their myogenic memory (Cappellari et al.,
2013). Unlike satellite cells, pericytes can cross blood vessel walls
and migrate into skeletal muscle tissue (Dellavalle et al., 2007).
Therefore, satellite cells might acquire the ability to cross blood
vessels and form myofibers by using the methodology.
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Another problem is the difficulty of obtaining large numbers
of satellite cells from a donor. In addition, expansion of satel-
lite cells in vitro reduces their regenerative activity, as described
above (Montarras et al., 2005; Ikemoto et al., 2007). However,
several studies have shed light on ways to improve the culture sys-
tem. Gilbert et al. indicated the importance of substrate elasticity
in sustaining satellite cell function in vitro (Gilbert et al., 2010).
Notch ligand stimulation also allows the expansion of satellite
cells without a decrease in vivo regenerative potential (Parker
et al., 2012). As described above, recent studies have indicated
that Notch signaling is one of the essential signaling pathways
to maintain satellite cells. The reason why Notch signals improve
myogenic cell transplantation is unknown, but one possibility is
the down-regulation of MyoD. Asakura et al. demonstrated that
the survival of MyoD-null mice-derived myoblasts is superior to
that of wild-type myoblasts (Asakura et al., 2007). The authors
also showed that many anti-apoptotic genes were up-regulated
in MyoD-null myoblasts, whereas genes known to execute apop-
tosis were down-regulated. The relationship between Notch and
MyoD in an improved protocol for myogenic cell transplantation
must be revealed for realization of satellite cell therapy for DMD
patients because Notch signaling also affects cell cycle genes in
satellite cells.
Another source of cells for therapy for muscle disorders is iPS
cell-derived myogenic cells (Mizuno et al., 2010; Darabi et al.,
2012). A method to produce myogenic cells from iPS cells, which
have some of the same features as satellite cells, might solve the
problem of cell numbers. Because satellite cells are mitotically
quiescent, we need to generate proliferating myogenic cells that
have myogenic potential similar to satellite cells. The myogenic
cell appearing in embryonic and neonatal developmental stages is
one model candidate for a myogenic progenitor derived from iPS
cells. However, Sakai et al. compared the regenerative potential of
fetal and adult satellite cells, and found that adult satellite cells are
superior to fetal satellite cells (Sakai et al., 2013). Researchers have
just begun to understand the satellite cell on the molecular level.
For the development of satellite cell-like cells from iPS cells, we
need to understand the process of generating satellite cells dur-
ing development as well as regeneration. Relaix et al. observed
that Pax3(+)Pax7(+) cells derived from the central region of
the dermomyotome are the origin of satellite cells (Relaix et al.,
2005). In addition, satellite cells express MyoD during this pro-
cess (Kanisicak et al., 2009). The Notch signaling pathway perhaps
down-regulates MyoD to generate the satellite cell pool. However,
before they become myogenin(+) cells, we cannot anticipate the
destiny of MyoD(+) myogenic cells during the development and
regeneration processes. One of the most important questions is
how the satellite cell pool is established during embryonic and
postnatal development. Understanding this will lead to success in
the generation of satellite cell-like cells from iPS cells.
The physiological self-renewal mechanism of satellite cells dur-
ing regeneration must also be revealed. Some evidences have
indicated an asymmetrical model of self-renewal of satellite cells
(Conboy and Rando, 2002; Shinin et al., 2006; Kuang et al., 2007).
Wnt7a signaling promotes symmetrical division of Myf5- satel-
lite cells and ameliorates the mdx phenotype (Le Grand et al.,
2009; von Maltzahn et al., 2012). Elucidation of these processes
may also lead to successful generation of satellite cell-like cells
from iPS cells. Taken together, in either case (satellite cells or iPS
cells), the molecular mechanisms for both generation, mainte-
nance, and self-renewal of satellite cells must be revealed to attain
our goal.
In addition, another mechanism must be understood for the
successful cell transplantation for muscle disorders. To date, we
have not paid attention to the fusion process between trans-
planted cells and myofibers. When donor cells are transplanted,
they have to cross the basal lamina and fuse with myofibers.
Horsley et al. indicated the myotube-myoblast fusion process
requires IL4/IL-4R signaling mediated by NFATc2 (Horsley et al.,
2003). However, the structure, functions, and gene expressions of
myotubes differ remarkably from those of myofibers. Therefore,
we need to consider the process of myoblast-with-myofiber
fusion. The identification of such genes will improve the efficiency
of satellite cell/iPS-derived myogenic cell therapy.
PROSPECTS
For 10 years, the isolation, characterization, and molecular reg-
ulation of satellite cells have been studied, and accumulating
evidence is starting to reveal the molecular mechanisms for main-
taining the satellite cell pool. In addition, recent studies are
beginning to identify the roles of satellite cells in several differ-
ent disorders. For instance, McCarthy et al. indicated that acute
hypertrophy is not dependent on satellite cells (McCarthy et al.,
2011). On the other hand, acute and chronic regenerations are
required to fulfill the potential of satellite cells. These results indi-
cate that not all muscle-related disorders depend on satellite cell
function. In the aging process, the dependence on satellite cells is
controversial. To develop a new therapeutic approach, we have to
understand the contribution of satellite cells to each disease. In
sarcopenia research, a Pax7-CreERT2::Rosa-DTA strategy might
be useful to elucidate the dependency of satellite cells. In addi-
tion, until now, the genes causing muscular dystrophies have only
been considered as a function of the sarcolemma in myofibers.
However, some of them are expressed in quiescent satellite cells
(Cohn et al., 2002; Fukada et al., 2007; Gnocchi et al., 2009).
Therefore, they may regulate the quiescence and undifferentiated
states of satellite cells, and additional functions of causative genes
in satellite cells might explain the severity of each disease.
The generation of iPS cells has assisted the cell therapy
approach to many disorders including muscular dystrophy
(Takahashi and Yamanaka, 2006; Takahashi et al., 2007). The suc-
cessful establishment of iPS cells was supported by studies of ES
cells. Finding culture conditions that can maintain ES cells in
an undifferentiated state is probably the most important contri-
bution to the birth of iPS cells. For cell treatment of muscular
disorders, we have at least two choices, satellite cells or iPS-derived
myogenic cells. In either case, we would like to reiterate that
understanding the molecular mechanisms of muscle satellite cells
is essential to accomplish successful myogenic cell therapy.
Skeletal muscle is indispensable for motility. In addition, skele-
tal muscle has the potential to control other tissues. For instance,
Bostrom et al. showed that a skeletal muscle-derived cytokine,
irisin, converts white fat cells to brown fat-like cells (Bostrom
et al., 2012). The relationship between exercise and immune
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function is a well-known open window theory (Nieman and
Pedersen, 1999). Thus, skeletal muscle itself might be a therapeu-
tic target for other diseases like diabetes. Much still remains to
be revealed about striated muscle, but striated muscle might have
many powers to control unanticipated physiologies. We hope that
the study of satellite cells will open new doors of striated muscle
biology and lead to a recovery of muscle power in muscle disorder
patients.
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